The One+ offering with the sensor, app and receiver. [Image courtesy of Dexcom] The FDA’s recall database today posted notices related to a Class I recall for continuous glucose monitor (CGM) ...

DexCom’s patent involves a glucose monitoring system with a sensor that calculates in vivo sensitivity without needing a reference analyte measurement post-insertion. The system uses in vitro ...